CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2017	Jan. 31, 2016
Cash flows from operating activities:
Net income	$ 2,039	$ 5,892
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	10,315	10,747
Amortization of deferred financing costs	477	477
Share-based compensation expense	3,042	2,582
(Gains) losses on assets, net	125	(2,589)
Provision for doubtful accounts	1,586	1,467
Provision for deferred income taxes	26	1,992
Excess tax (benefits) shortfalls from share-based compensation arrangements	(1,515)	261
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	19,181	23,669
Inventories	(4,932)	7,469
Income taxes receivable	(6,777)	0
Prepaid expenses and other	2,157	1,899
Accounts payable	(30,199)	(35,619)
Accrued expenses	(27,240)	(22,100)
Other, net	(163)	(347)
Net cash used in operating activities	(31,878)	(4,200)
Cash flows from investing activities:
Acquisitions, net of cash acquired	0	(3,071)
Capital expenditures	(4,120)	(5,772)
Proceeds from sale of property, plant and equipment	0	3,066
Net cash used in investing activities	(4,120)	(5,777)
Cash flows from financing activities:
Refund (deposit) of restricted cash	117	(93)
Proceeds from stock options exercised	1,019	0
Excess tax benefits (shortfalls) from share-based compensation arrangements	1,515	(261)
Proceeds from Amended ABL facility	30,000	0
Payments on Amended ABL facility	(30,000)
Payments on term loan	(10,000)	(10,000)
Payments on note payable	(431)	(514)
Purchases of treasury stock	(5,922)	(4,627)
Net cash used in financing activities	(13,702)	(15,495)
Effect of exchange rate changes on cash and cash equivalents	86	(341)
Net decrease in cash and cash equivalents	(49,614)	(25,813)
Cash and cash equivalents at beginning of period	65,403	99,662
Cash and cash equivalents at end of period	$ 15,789	$ 73,849